Transplantation organ preservation transport system LifePort

livercompactbenchtop

LifePort Liver Transporter design, engineering, and performance capabilities are based upon the LifePort prototype system used in the Columbia University Medical Center / New York Presbyterian Hospital and the proven technology platform of the market leading LifePort Kidney Transporter. LifePort Liver Transporter has not been cleared or approved by FDA, and the safety and effectiveness of the LifePort Liver Transporter has not been established. LifePort Liver Transporter is not available for sale. US Clinical Trials PILOT (Perfusion to Improve Liver Outcomes in Transplantation), NCT03484455 was a prospective randomized multi-center oxygenated hypothermic machine perfusion study using the LifePort Liver Transporter (LLT) system with Vasosol® as compared to static cold storage in orthotopic liver transplantation. PILOT_CA (Perfusion to Improve Liver Outcomes in Transplantation: Continued Access Arm), NCT05574361 is a prospective non-randomized multi-center study using the LLT system with Vasosol orthotopic liver transplants.